From: Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy
Gender
Number
(%)
Male
12
70.6%
Female
5
29.4%
Histology
Adenocarcinoma
2
11.8%
Squamous cell
13
76.4%
Other
Initial cT
cT1
1
5.9%
cT2
3
17.6%
cT3
4
23.5%
cT4
9
53%
Age (years)
Median
Range
54
41 – 78